Miti Health is honored and delighted to announce that we have received additional support from Stanford through the Center for Innovation in Global Health (CIGH) Pilot Project Awards. Both CIGH and the Biodesign program have been incredible supporters of ours from the very start.
After our customer research in Kenya last summer, we had some time to reflect, and we realized how much fragmentation and inefficiencies in the medication supply chain in Kenya were adversely affecting health outcomes for patients. The pharmacists that we met were constantly running out of medication and often needed to reorder medication every single day, working with an average of 6 different suppliers to get the medication that they needed. And in many cases, they had very little information about the quality of drugs that they were receiving. Given what we found in our market research, we weren’t surprised to learn that 30% of medication distributed in Africa is counterfeit or substandard – with such a fragmented and ad-hoc system, how could patients or pharmacists know which drugs were good?
As we thought more about this huge problem, we realized that we needed to learn more and design our system to specifically address this issue. We were lucky that someone with incredible supply chain expertise was interested in leading this work, and that Stanford was once-again willing to throw support behind an energetic team with a crazy idea. And we’re excited to share what we learn and the systems that we design.
